Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.32% is 76% below its 5-year average of 5.46%, near the low end of its 5-year range (1.32%–16.11%).
As of the fiscal period ended Tuesday, June 30, 2026. 60.43% below its 12-month average of 3.34%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.32%.
DEBT TO ASSETS RATIO
1.32%
DEBT TO ASSETS RATIO AVG TTM
3.34%
DEBT TO ASSETS RATIO AVG 3Y
5.16%
DEBT TO ASSETS RATIO AVG 5Y
5.46%
DEBT TO ASSETS RATIO AVG 10Y
4.03%
DEBT TO ASSETS RATIO AVG 15Y
2.74%
DEBT TO ASSETS RATIO AVG 20Y
2.01%
CURRENT VS TTM AVG
-60.43%
CURRENT VS 3Y AVG
-74.35%
CURRENT VS 5Y AVG
-75.75%
CURRENT VS 10Y AVG
-67.19%
CURRENT VS 15Y AVG
-51.76%
CURRENT VS 20Y AVG
-34.16%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 576 covered companies
CURRENT VS SECTOR MEDIAN
+1222.87%
vs the sector median at left
Arbutus Biopharma Corp
Market Cap
$879.04M
Debt to Assets Ratio
1.32%
TTM Avg
3.34%
3Y Avg
5.16%
5Y Avg
5.46%
Market Cap
$864.50M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$845.05M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$844.91M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$911.51M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$921.92M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$923.59M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $879.04M | 1.32% | 3.34% | 5.16% | 5.46% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $864.50M | 0.00% | N/A | N/A | N/A |
| Bioventus Inc. (BVS)vs › | $901.05M | 0.39% | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $845.05M | 0.05% | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $844.91M | 0.02% | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $911.51M | 0.03% | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $921.92M | 0.04% | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $923.59M | 0.18% | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $826.99M | 0.06% | N/A | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $932.37M | 0.13% | N/A | N/A | N/A |
Debt/Assets
1.3%
Debt/Equity
0.01
Current Ratio
81.42
Interest Coverage
-278.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.32% |
| 2026-03-31 | 1.41% |
| 2025-12-31 | 4.43% |
| 2025-09-30 | 4.71% |
| 2025-06-30 | 4.84% |
| 2025-03-31 | 4.78% |
| 2024-12-31 | 4.65% |
| 2024-09-30 | 4.81% |
| 2024-06-30 | 4.66% |
| 2024-03-31 | 5.38% |
| 2023-12-31 | 6.04% |
| 2023-09-30 | 6.32% |
| 2023-06-30 | 6.12% |
| 2023-03-31 | 6.01% |
| 2022-12-31 | 6.42% |
| 2022-09-30 | 7.18% |
| 2022-06-30 | 7.74% |
| 2022-03-31 | 7.59% |
| 2021-12-31 | 9.25% |
| 2021-09-30 | 12.45% |
| 2021-06-30 | 16.11% |
| 2021-03-31 | 15.23% |
| 2020-12-31 | 16.44% |
| 2020-09-30 | 17.72% |
| 2020-06-30 | 23.53% |
| 2020-03-31 | 3.21% |
| 2019-12-31 | 3.18% |
| 2019-09-30 | 2.96% |
| 2019-06-30 | 1.89% |
| 2019-03-31 | 1.85% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.27% |
| 2018-06-30 | 0.25% |
| 2018-03-31 | 0.26% |
| 2017-12-31 | 5.06% |
| 2017-09-30 | 5.00% |
| 2017-06-30 | 4.70% |
| 2017-03-31 | 4.48% |
| 2016-12-31 | 4.35% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.02% |
| 2008-06-30 | 0.05% |
| 2008-03-31 | 0.23% |
| 2007-12-31 | 0.31% |
| 2007-09-30 | 0.45% |
| 2007-06-30 | 0.47% |
